Inhibition of adenosine deaminase attenuates inflammation in experimental colitis. - Test2 - elhamkhani - TriplyDB

Inhibition of adenosine deaminase attenuates inflammation in experimental colitis.

Inhibition of adenosine deaminase attenuates inflammation in experimental colitis.

http://www.wikidata.org/entity/Q34654041

about

Purinergic signalling in the gastrointestinal tract and related organs in health and disease Potential for developing purinergic drugs for gastrointestinal diseases Targeting the A2B adenosine receptor during gastrointestinal ischemia and inflammation Feed-forward inhibition of CD73 and upregulation of adenosine deaminase contribute to the loss of adenosine neuromodulation in postinflammatory ileitis.The resurgence of A2B adenosine receptor signaling Relevance of TNBS-colitis in rats: a methodological study with endoscopic, histologic and Transcriptomic [corrected] characterization and correlation to IBD.Diet- and Genetically-Induced Obesity Differentially Affect the Fecal Microbiome and Metabolome in Apc1638N Mice Sampling protein motion and solvent effect during ligand binding Epithelial-specific A2B adenosine receptor signaling protects the colonic epithelial barrier during acute colitis Anti-inflammatory effects of purine nucleosides, adenosine and inosine, in a mouse model of pleurisy: evidence for the role of adenosine A2 receptors.Alteration of colonic excitatory tachykininergic motility and enteric inflammation following dopaminergic nigrostriatal neurodegeneration.Pharmacological modulation of adenosine system: novel options for treatment of inflammatory bowel diseases.Adenosine: an immune modulator of inflammatory bowel diseases.Role of the A(2B) receptor-adenosine deaminase complex in colonic dysmotility associated with bowel inflammation in rats.Adenosine and adenosine receptors: Newer therapeutic perspective.Design and application of locally delivered agonists of the adenosine A(2A) receptor.Moonlighting adenosine deaminase: a target protein for drug development.Development of novel treatment strategies for inflammatory diseases-similarities and divergence between glucocorticoids and GILZ.Purinergic Signalling in the Gut.Adenosine A(2A) agonist and A(2B) antagonist mediate an inhibition of inflammation-induced contractile disturbance of a rat gastrointestinal preparation.Erythro-9-(2-hydroxy-3-nonyl)adenine (EHNA) blocks differentiation and maintains the expression of pluripotency markers in human embryonic stem cells.An integrated assessment of histopathological changes of the enteric neuromuscular compartment in experimental colitis.Utilization of real-time electrospray ionization mass spectrometry to gain further insight into the course of nucleotide degradation by intestinal alkaline phosphatase.Vitamin U has a protective effect on valproic acid-induced renal damage due to its anti-oxidant, anti-inflammatory, and anti-fibrotic properties.Control of enteric neuromuscular functions by purinergic A(3) receptors in normal rat distal colon and experimental bowel inflammation Unveiling the binding mode of adenosine deaminase inhibitors to the active site of the enzyme: implication for rational drug design : presented by Maria P. Abbracchio.Inhibition of the NF-κB and p38 MAPK pathways by scopoletin reduce the inflammation caused by carrageenan in the mouse model of pleurisy.Hepatoprotective effects of lycopene on liver enzymes involved in methionine and xenobiotic metabolism in hyperhomocysteinemic rats.Evaluation of acetylcholinesterase and adenosine deaminase activities in brain and erythrocytes and proinflammatory cytokine levels in rats submitted to neonatal hypoxia-ischemia model.Anti-inflammatory effect of a novel locally acting A2A receptor agonist in a rat model of oxazolone-induced colitis.No association between serum adenosine deaminase activity and disease activity in Crohn's disease.Methionine and/or Methionine Sulfoxide Alter Ectoenzymes Activities in Lymphocytes and Inflammatory Parameters in Serum from Young Rats: Acute and Chronic Effects.The flavonoid compound apigenin prevents colonic inflammation and motor dysfunctions associated with high fat diet-induced obesity.Adenosine A2A receptor contributes to the anti-inflammatory effect of the fixed herbal combination STW 5 (Iberogast®) in rat small intestinal preparations.Purinergic Ligands as Potential Therapeutic Tools for the Treatment of Inflammation-Related Intestinal Diseases.Derivatives of Benzimidazol-2-ylquinoline and Benzimidazol-2-ylisoquinoline as Selective A1 Adenosine Receptor Antagonists with Stimulant Activity on Human Colon Motility

P2860

Q26861086-6FABF208-81F1-4AEA-8852-07C8F2CD02DD Q27000719-BE978C46-BAD0-4EC1-BF62-73CC0DE179D3 Q33830064-020A4CC9-D4D2-416D-A2CE-7FC9FCBB6373 Q34125472-708E5981-5D81-4EE0-B2E3-ADB9C9B87923 Q34307284-9396D78E-2DFC-4D9B-9392-883AEDAF8FAD Q34575468-B3D6783D-C53B-4410-ADF0-64DF91E47E6A Q35748788-2C52BEDF-A2A9-4E6F-8B66-437DD5BEE058 Q35749668-0BAD4840-9D26-49BF-97B4-21EBDFBBA4DE Q36137545-C195066B-28CB-4763-A848-535B69ADB3F0 Q36362887-184586F4-F8F4-4C40-A83B-452F88A628D8 Q37002601-7B0ED031-07D8-4C36-806A-F064260CA60E Q37006166-194B571C-1484-4E51-985F-5510DC4B1347 Q37362853-E6B6A841-597D-40DC-8D2B-0FB5AB150A1A Q37635280-8357B2E1-B8FA-4BF8-9019-FE9037B2C698 Q37742448-CA99BBD8-5696-4719-A83C-89D270694A25 Q37960072-7FEA49B1-EE99-44DD-AAEB-A3168AE619FE Q38220597-2670632B-B761-4A1F-93C2-5A6DBAFFB0CC Q38237635-5FEE0655-66B8-46B4-A518-B032AD704FCF Q38886416-166E69B4-A61D-49E8-8C04-E95642D80D06 Q39600697-1AEEC28E-AEBE-4B89-84EE-845692F0FAE4 Q39648017-238DF665-9E26-4E4D-A255-D5D97790554D Q39901570-401310C2-1F26-4301-A725-6351DF13B81C Q40177157-C514B2B0-3DAE-488B-BEDF-F8271F669255 Q41173251-26212079-F055-4383-828A-78214DDCE532 Q41474088-E7D65EA3-8611-45BA-826B-9EC528454BB5 Q41940564-A5EA8785-42B6-49D0-ADDF-9DFF741A68B3 Q46529719-5D10BB90-9423-4C56-AD4A-4CB65BDAB426 Q46592703-C2177FBC-5A74-4573-BDDC-B48CED97FCD3 Q48117133-72EFB611-D043-4C22-8F23-63B02BB3228F Q50108353-906E4CD2-8216-4B86-AE90-2F7BE44B0937 Q50587883-6BABEB17-5897-4428-8F0F-9A36380D8131 Q50880829-946A90F1-3FE8-47DB-8D5A-F90CC8F47351 Q52594157-C16DE025-3EDF-4421-8802-2B763D02F08B Q54334590-EAFD310E-DF6E-4674-A51B-C24E8A34B975 Q55340359-6ACD8B46-4760-4FC6-AF70-E467BB09C7E3 Q58855712-C5EE0C27-91F3-4141-A45F-6C53FAE759F7

P2860

Inhibition of adenosine deaminase attenuates inflammation in experimental colitis.

http://www.wikidata.org/entity/Q34654041

description

2007 nî lūn-bûn

@nan

2007 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

Inhibition of adenosine deaminase attenuates inflammation in experimental colitis.

@ast

Inhibition of adenosine deaminase attenuates inflammation in experimental colitis.

@en

Inhibition of adenosine deaminase attenuates inflammation in experimental colitis.

@nl

type

label

Inhibition of adenosine deaminase attenuates inflammation in experimental colitis.

@ast

Inhibition of adenosine deaminase attenuates inflammation in experimental colitis.

@en

Inhibition of adenosine deaminase attenuates inflammation in experimental colitis.

@nl

prefLabel

Inhibition of adenosine deaminase attenuates inflammation in experimental colitis.

@ast

Inhibition of adenosine deaminase attenuates inflammation in experimental colitis.

@en

Inhibition of adenosine deaminase attenuates inflammation in experimental colitis.

@nl

P1433

Q34654041-7FAF777E-2E81-4082-80FE-32BDF7B8C019

P1476

Q34654041-F3CA0CD7-9953-47AB-AA9E-AD1FB8D6AC40

P2093

Q34654041-0260DF98-38CC-436E-A2F9-D5F2F7C642F5

Q34654041-0BBD666A-142E-46EF-A25E-B49A38B3A3F6

Q34654041-35FE985C-9668-49F2-B38C-00852E1D0905

Q34654041-60B5A337-1A0F-4E9E-9217-8D0E52E032B2

Q34654041-6214EADE-1E7F-4308-8F14-AA529B0F554F

Q34654041-628C7BCF-3ADF-4B80-A70A-1139045B4FC2

Q34654041-91558742-BF50-494C-BCD2-8E07EA3AC99F

Q34654041-9B0DAC0B-E756-4681-A888-AEC80CC56465

Q34654041-9D79E419-572A-4C54-8550-651D1DD08344

Q34654041-D5EB6A88-B072-42F9-A575-A4780C21A28F

P304

Q34654041-C61F490B-18CE-466E-9642-840CCCAF1FEA

P31

Q34654041-2A5EBBEB-C35C-4F9A-A8D7-2AB43DFE3E3E

P356

Q34654041-DE9F1363-1DCE-4F86-A67D-9278FF00F42B

P407

Q34654041-87CD417F-6C4F-4973-89CE-6B52DC7BAF75

P433

Q34654041-5D20C213-6815-4781-A584-6272366C35AA

P478

Q34654041-4FCB1A54-4420-44FA-A087-99854C6929E6

P50

Q34654041-20CF3765-7577-4E0A-9A47-8265A30E401A

Q34654041-971A906C-B9BD-46A6-BA07-FB30BE739972

Q34654041-AA1D8B27-ABBD-4E32-A346-339AEF6A7539

Q34654041-BE73BE3D-0DDB-48A7-9BC3-E95B5AFDBA44

Q34654041-EDA2106A-1344-4F13-96E3-95568770108A

P577

Q34654041-03148994-FE3B-4B2C-90CE-8C8AB26330B1

P5875

Q34654041-97717103-8AB4-4B12-8EA1-EEF79073EF44

P698

Q34654041-4469244C-AB2C-47C3-B2F1-A072DDBC6794

P921

Q34654041-7512277D-176A-4BC8-B724-9BF2FDF55E79

P356

JPET.107.122762

P1433

Journal of Pharmacology and Experimental Therapeutics

P1476

Inhibition of adenosine deaminase attenuates inflammation in experimental colitis

@en

P2093

Agostino Virdis

http://www.w3.org/2001/XMLSchema#string

Cristina Vassalle

http://www.w3.org/2001/XMLSchema#string

Emiliano Duranti

http://www.w3.org/2001/XMLSchema#string

Laura Mugnaini

http://www.w3.org/2001/XMLSchema#string

Luca Antonioli

http://www.w3.org/2001/XMLSchema#string

Maria Cristina Breschi

http://www.w3.org/2001/XMLSchema#string

Mario Del Taca

http://www.w3.org/2001/XMLSchema#string

Narcisa Ghisu

http://www.w3.org/2001/XMLSchema#string

Olga Kastsiuchenka

http://www.w3.org/2001/XMLSchema#string

Rocchina Colucci

http://www.w3.org/2001/XMLSchema#string

P304

435-442

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1124/JPET.107.122762

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

322

http://www.w3.org/2001/XMLSchema#string

P50

Concettina La Motta

Federico Da Settimo Passetti

Gianfranco Natale

Corrado Blandizzi

P577

2007-05-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6342344

http://www.w3.org/2001/XMLSchema#string

P698

17488880

http://www.w3.org/2001/XMLSchema#string

P921